BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 9514425)

  • 1. Use of guanylyl cyclase C for detecting micrometastases in lymph nodes of patients with colon cancer.
    Waldman SA; Cagir B; Rakinic J; Fry RD; Goldstein SD; Isenberg G; Barber M; Biswas S; Minimo C; Palazzo J; Park PK; Weinberg D
    Dis Colon Rectum; 1998 Mar; 41(3):310-5. PubMed ID: 9514425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guanylyl cyclase C messenger RNA is a biomarker for recurrent stage II colorectal cancer.
    Cagir B; Gelmann A; Park J; Fava T; Tankelevitch A; Bittner EW; Weaver EJ; Palazzo JP; Weinberg D; Fry RD; Waldman SA
    Ann Intern Med; 1999 Dec; 131(11):805-12. PubMed ID: 10610624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of GUCY2C expression in lymph nodes with time to recurrence and disease-free survival in pN0 colorectal cancer.
    Waldman SA; Hyslop T; Schulz S; Barkun A; Nielsen K; Haaf J; Bonaccorso C; Li Y; Weinberg DS
    JAMA; 2009 Feb; 301(7):745-52. PubMed ID: 19224751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of occult metastasis in lymph nodes from colorectal cancer patients: a multiple-marker reverse transcriptase-polymerase chain reaction study.
    Chen G; McIver CM; Texler M; Lloyd JM; Rieger N; Hewett PJ; Sen Wan D; Hardingham JE
    Dis Colon Rectum; 2004 May; 47(5):679-86. PubMed ID: 15037935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of guanylyl cyclase C lymph node status for colon cancer staging and prognosis.
    Sargent DJ; Resnick MB; Meyers MO; Goldar-Najafi A; Clancy T; Gill S; Siemons GO; Shi Q; Bot BM; Wu TT; Beaudry G; Haince JF; Fradet Y
    Ann Surg Oncol; 2011 Nov; 18(12):3261-70. PubMed ID: 21533822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guanylyl cyclase C is a selective marker for metastatic colorectal tumors in human extraintestinal tissues.
    Carrithers SL; Barber MT; Biswas S; Parkinson SJ; Park PK; Goldstein SD; Waldman SA
    Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14827-32. PubMed ID: 8962140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of occult metastases in colon cancer.
    Merrie AE; van Rij AM; Dennett ER; Phillips LV; Yun K; McCall JL
    Dis Colon Rectum; 2003 Feb; 46(2):221-31. PubMed ID: 12576896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrinsic variability in the detection of micrometastases in lymph nodes for re-staging of colorectal cancer. effect of individual markers and tissue samples.
    Salto-Tellez M; Kong SL; Leong AP; Koay ES
    Eur J Cancer; 2003 Jun; 39(9):1234-41. PubMed ID: 12763211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A validated quantitative assay to detect occult micrometastases by reverse transcriptase-polymerase chain reaction of guanylyl cyclase C in patients with colorectal cancer.
    Schulz S; Hyslop T; Haaf J; Bonaccorso C; Nielsen K; Witek ME; Birbe R; Palazzo J; Weinberg D; Waldman SA
    Clin Cancer Res; 2006 Aug; 12(15):4545-52. PubMed ID: 16899600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guanylyl cyclase C: a molecular marker for staging and postoperative surveillance of patients with colorectal cancer.
    Frick GS; Pitari GM; Weinberg DS; Hyslop T; Schulz S; Waldman SA
    Expert Rev Mol Diagn; 2005 Sep; 5(5):701-13. PubMed ID: 16149873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of histopathology and RT-qPCR amplification of guanylyl cyclase C for detection of colon cancer metastases in lymph nodes.
    Haince JF; Houde M; Beaudry G; L'espérance S; Garon G; Desaulniers M; Hafer LJ; Heald JI; Lyle S; Grossman SR; Têtu B; Sargent DJ; Fradet Y
    J Clin Pathol; 2010 Jun; 63(6):530-7. PubMed ID: 20498026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Escherichia coli heat-stable enterotoxin receptors. A novel marker for colorectal tumors.
    Carrithers SL; Parkinson SJ; Goldstein SD; Park PK; Urbanski RW; Waldman SA
    Dis Colon Rectum; 1996 Feb; 39(2):171-81. PubMed ID: 8620784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokeratin 20 and guanylyl cyclase C mRNA is largely present in lymph node and liver specimens of colorectal cancer patients.
    Conzelmann M; Dieterle CP; Linnemann U; Berger MR
    Int J Cancer; 2003 Nov; 107(4):617-28. PubMed ID: 14520701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A splice variant of the transcript for guanylyl cyclase C is expressed in human colon and colorectal cancer cells.
    Pearlman JM; Prawer SP; Barber MT; Parkinson SJ; Schulz S; Park J; Zook M; Waldman SA
    Dig Dis Sci; 2000 Feb; 45(2):298-305. PubMed ID: 10711442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Value of Molecular Detection of Lymph Node Metastases After Curative Resection of Stage II Colon Cancer: A Systematic Pooled Data Analysis.
    Gill S; Haince JF; Shi Q; Pavey ES; Beaudry G; Sargent DJ; Fradet Y
    Clin Colorectal Cancer; 2015 Jun; 14(2):99-105. PubMed ID: 25619805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular testing for lymph node metastases as a determinant of colon cancer recurrence: results from a retrospective multicenter study.
    Sargent DJ; Shi Q; Gill S; Louvet C; Everson RB; Kellner U; Clancy TE; Pipas JM; Resnick MB; Meyers MO; Wu TT; Huntsman D; Validire P; Farooq U; Pavey ES; Beaudry G; Haince JF; Fradet Y
    Clin Cancer Res; 2014 Aug; 20(16):4361-9. PubMed ID: 24919572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ectopic expression of guanylyl cyclase C in CD34+ progenitor cells in peripheral blood.
    Fava TA; Desnoyers R; Schulz S; Park J; Weinberg D; Mitchell E; Waldman SA
    J Clin Oncol; 2001 Oct; 19(19):3951-9. PubMed ID: 11579116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the intestinal biomarkers Guanylyl cyclase C and CDX2 in poorly differentiated colorectal carcinomas.
    Winn B; Tavares R; Matoso A; Noble L; Fanion J; Waldman SA; Resnick MB
    Hum Pathol; 2010 Jan; 41(1):123-8. PubMed ID: 19800103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymph node CXCL17 messenger RNA: A new prognostic biomarker for colon cancer.
    Rashad Y; Olsson L; Israelsson A; Öberg Å; Lindmark G; Hammarström ML; Hammarström S; Sitohy B
    Tumour Biol; 2018 Sep; 40(9):1010428318799251. PubMed ID: 30198422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Previstage GCC colorectal cancer staging test: a new molecular test to identify lymph node metastases and provide more accurate information about the stage of patients with colorectal cancer.
    Carlson MR
    Mol Diagn Ther; 2009; 13(1):11-4. PubMed ID: 19351210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.